% !TEX program = xelatex
\documentclass{beamer}
% \usepackage[utf8]{inputenc}
% \usepackage[T1]{fontenc}
% \usepackage[english]{babel}
% \usepackage{csquotes}

% with xelatex
\usepackage{fontspec}  % fontspec et xunicode sont facultatifs
\usepackage{xunicode}  % pour les versions postérieures à 2018.

% \usepackage[a4paper, left=2.5cm,right=2.5cm,top=2.5cm,bottom=2.5cm]{geometry}
\setlength{\parindent}{1em}
% \setlength{\parskip}{1em}
\usepackage{indentfirst}

\usepackage[sfdefault,lining]{FiraSans} %% option 'sfdefault' activates Fira Sans as the default text font
\usepackage[fakebold]{firamath-otf}
\renewcommand*\oldstylenums[1]{{\firaoldstyle #1}}

\usepackage[none]{hyphenat}

\usepackage{graphicx}

\usepackage{biblatex}

\title{
  \textbf{Monoclonal Antibody Therapy}
}
\author{Louis-Justin Tallot}
\date{February 2022}

\titlegraphic{\centering\vspace{7cm}\includegraphics[width=0.3\textwidth]{../Images/Logo_Mines_ParisTech.png}}


% \bibliographystyle{plain}
\bibliography{report_therapy_monoclonal_antibodies}

\begin{document}
  \maketitle
  \end{frame}



  \section*{Introduction}
  \input{sections/0_introduction.tex}

  \section{What is a monoclonal antibody ?}

    \subsection{What is an antibody ?}
    \input{sections/1.1_what_is_an_antibody.tex}

    \subsection{Difference between monoclonal and polyclonal antibodies}
    \input{sections/1.2_difference_monoclonal_polyclonal.tex}

    \subsection{Production of monoclonal antibodies}
    \input{sections/1.3_production_monoclonal_antibodies.tex}

    \subsection{Characteristics of a monoclonal antibody}
    \input{sections/1.4_characteristics_monoclonal_antibody.tex}

  \section{How are monoclonal antibodies used for therapy ?}

    \subsection{Therapeutic activity of monoclonal antibodies}
    \input{sections/2.1_therapeutic_activity.tex}

    \subsection{Commercial uses}
    \input{sections/2.2_commercial_uses.tex}

    \subsection{Market analysis}
  
  
  \section*{Conclusion}

\end{document}
